Target Choline (membrane metabolism)Class Choline analogueOther names fluoromethylcholine, FCH
Structure from the cited PubChem record (unlabelled ligand, or the labelled form when PubChem only describes that one). Conformer: PubChem (3D conformer computed by PubChem). Rotate with the mouse or a finger.
| Form | Use | Molar mass (labelled form) | Ongoing trials | Most advanced phase | Approval |
|---|---|---|---|---|---|
| [¹⁸F]fluorocholine Syntheses and QC ↗ | Imaging | 121.16 | 11 | Phase 3 | Choline ([11C] Mayo, [18F] IASOcholine…) US EU FR |
| [¹¹C]choline Syntheses and QC ↗ | Imaging | 103.17 | 0 | — | Choline ([11C] Mayo, [18F] IASOcholine…) US EU FR |
Atlas trials whose studied drug or title names this vector, with this radionuclide.
| Trial | Phase | Status | Sponsor | Countries |
|---|---|---|---|---|
| Labeled choline ([18F]/[11C])2025-520861-29-00 · Prostate – other | Phase 3 | Not yet recruiting | A.C.O.M. Advanced Center Oncology Macerata S.r.l. | 1 |
| Labeled choline ([18F]/[11C])NCT04150458 · Other | Phase 3 | By invitation | Sir Mortimer B. Davis - Jewish General Hospital | 1 |
| F-choline · Labeled choline ([18F]/[11C])NCT04999215 · Other | Phase 3 | Recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Labeled choline ([18F]/[11C])NCT07444723 · Hyperparathyroidism | Phase 3 | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| ADACHOL · Brain receptors, transporters and enzymesNCT03998852 · Other | Phase 3 | Recruiting | University Hospital, Bordeaux | 1 |
| Brain receptors, transporters and enzymesNCT05231798 · Alzheimer's disease and cognitive disorders | Phase 2 | Recruiting | Vanderbilt University Medical Center | 1 |
| ExTRACT-HCC · Labeled choline ([18F]/[11C])NCT04965454 · Liver (HCC) | Phase 2 | Recruiting | Queen's Medical Center | 1 |
| Labeled choline ([18F]/[11C])NCT07138820 · Hyperparathyroidism | No phase | Recruiting | Region Skane | 1 |
| Labeled choline ([18F]/[11C])NCT05359939 · Liver (HCC) | No phase | Recruiting | University of Aarhus | 1 |
| OPERANDI-HCC · Labeled choline ([18F]/[11C])NCT06334965 · Liver (HCC) | No phase | Recruiting | Assistance Publique - Hôpitaux de Paris | 1 |
| MIM · [18F]FDGNCT04349358 · Myeloma | No phase | Recruiting | Centre Georges Francois Leclerc | 1 |
| [68Ga]Ga-DOTA-TATE/TOC/NOC2024-519505-35-00 · Gastroenteropancreatic NETs | Phase 3 | Recruiting | Centre Hospitalier Universitaire De Nantes | 1 |
1,535 publications in PubMed for the query below; the most recent:
fluorocholine[tiab] OR fluoromethylcholine[tiab] OR "choline PET"[tiab]
Sources: PubChem and PubMed (NCBI), ClinicalTrials.gov and CTIS registries, approvals recorded by the atlas. PubChem data as of 28 October 2026.
Fluorocholine. Theranostic Atlas, LaRadiopharmacie.fr. Data as of 27 October 2026. https://theranosticatlas.com/molecule/fluorocholine/ (accessed [date]).
A monitoring tool with no regulatory value: check every item at its source.